Ershler. W B WB; Coe. C L CL; Laughlin. N N; Klopp. R G RG; Gravenstein. S S; Roecker. E B EB; Schul...
A short 7‑day study gave older female rhesus monkeys a peptide called thymosin‑alpha‑1 and found it was safe, but it didn’t clearly boost most immune measures. Some monkeys showed a slight rise in cell‑killing activity and cell growth, but the changes weren’t statistically solid, and the vaccine antibody response didn’t improve.
Garaci. E E; Mastino. A A; Pica. F F; Favalli. C C
In mice with lung cancer, giving thymosin‑alpha‑1 for four days, then a single dose of interferon after a chemotherapy shot, made the tumors disappear and helped the mice live longer. The combo boosted natural killer cells and brought more immune cells into the tumors, while each drug alone did little.
Mutchnick. M G MG; Lee. H H HH; Hollander. D I DI; Haynes. G D GD; Chua. D C DC
The study found that people with Crohn's disease or ulcerative colitis make less of the immune signal IFN‑gamma in lab tests, but their blood levels of the peptide thymosin‑alpha‑1 are the same as healthy folks, while another peptide, thymosin‑beta‑4, is higher. This means the IFN‑gamma problem isn’t due to low thymosin‑alpha‑1.
Panneerselvam. C C; Haritos. A A AA; Caldarella. J J; Horecker. B L BL
The study shows that the test used for thymosin‑alpha‑1 actually picks up a different protein, prothymosin‑alpha, which is naturally present in tiny amounts (about 55‑70 pmol per ml) mainly inside white blood cells, not in the plasma. This means the body’s baseline level of thymosin‑alpha‑1 is very low and mostly hidden inside cells.
Goya. R G RG; Naylor. P H PH; Goldstein. A L AL; Meites. J J
In rats, the hormone thymosin‑alpha‑1 drops as they get older, along with growth hormone and thyroid hormone T4, while the pituitary gland gets bigger and TSH rises. These changes are linked together, showing the aging immune‑endocrine system shifts in a predictable way.
Kouttab. N M NM; Goldstein. A L AL; Lu. M M; Lu. L L; Campbell. B B; Maizel. A L AL
The study shows that the synthetic peptide thymosin‑alpha‑1 can make immune cells produce more B‑cell and T‑cell growth signals, but only when those cells are already activated, and it works at much lower doses than older thymic extracts. This hints it might boost immune signaling, though the work was done in a lab dish, not in people.
Dubois. P P; Dardenne. M M; Fandeur. T T; Mercereau-Puijalon. O O; Mattei. D D; Müller-Hill. B...
Researchers found that some malaria proteins look a lot like the human immune‑boosting peptide thymosin‑alpha‑1, and the antibodies they made against the malaria pieces also stick to thymosin‑alpha‑1. The malaria pieces even act a bit like thymosin‑alpha‑1 in lab tests, suggesting the parasite may copy our immune signals to hide from us.
The paper looks at why some puppies and kittens waste away for no clear reason and points to a possibly faulty thymus gland. It notes that a few cases improved when given thymus‑derived hormones like thymosin‑alpha‑1 or growth hormone, but the evidence is limited and mostly in animals.
The study tested whether thymosin‑alpha‑1 and other thymic peptides boost the body’s prostaglandin production, which could explain some of their effects. In mouse spleen cells, none of the peptides changed prostaglandin levels, so prostaglandins are likely not the way these hormones work.
Schulof. R S RS; Chorba. T L TL; Cleary. P A PA; Palaszynski. S R SR; Alabaster. O O; Goldstein. A L...
Radiation treatment for lung cancer sharply lowers the number and function of immune cells called T‑cells, and this drop can last several months. In lab tests, adding the peptide thymosin‑alpha‑1 helped some patients' T‑cells work better, but the study didn’t test it in people after radiation. The findings suggest the peptide might aid immune recovery, but more clinical data are needed before using it on your own.
Baumann. C A CA; Badamchian. M M; Goldstein. A L AL
In mouse thymus cells, the peptide thymosin‑alpha‑1 can temporarily block cell death caused by the steroid drug dexamethasone, but only if it’s given before the drug and at fairly high concentrations. The protection lasts up to about 12 hours and doesn’t rely on making new proteins, but it doesn’t work against damage from hydrogen peroxide.
In mice, giving the peptide thymosin‑alpha‑1 helped protect the bone‑marrow from damage caused by the chemotherapy drug 5‑fluorouracil. It did this by boosting factors that support blood‑cell growth and by helping immature T‑cells mature into functional immune cells. The protective effect vanished when T‑cells were blocked, showing the peptide works through the immune system.
Ohta. Y Y; Tamura. S S; Nihira. S S; Tezuka. E E; Imai. S S; Yagi. Y Y
In mice, giving thymosin‑alpha‑1 a few times raised the number of blood‑forming colonies by making the body produce more of a growth factor called IL‑3. The peptide didn’t work directly on bone‑marrow cells in a dish, so its effect seems to be indirect through IL‑3. This hints it could help boost immune cell production, but the study is early‑stage and done in special mice, so we don’t yet know how to use it in people.
Stehr-Green. P A PA; Naylor. P H PH; Hoffman. R E RE
People who lived for a long time in an area contaminated with the chemical TCDD had lower blood levels of the immune‑boosting peptide thymosin‑alpha‑1. The drop got bigger the longer they lived there, but the study didn’t find a clear link to actual immune problems.
Zatz. M M MM; Oliver. J J; Samuels. C C; Skotnicki. A B AB; Sztein. M B MB; Goldstein. A L AL
In lab tests, adding thymosin to already‑stimulated immune cells made them produce more of a growth factor that helps T‑cells, especially in the first day, but the effect isn’t caused by the well‑known piece called thymosin‑alpha‑1. This hints that thymosin mixes might boost immunity, though we don’t yet know how to use it in people.
Caldarella. J J; Goodall. G J GJ; Felix. A M AM; Heimer. E P EP; Salvin. S B SB; Horecker. B L BL
Scientists found a new peptide called thymosin alpha 11 that’s similar to the well‑known immune‑boosting peptide thymosin alpha‑1, but with a few extra building blocks. In mice, tiny amounts (under 300 ng) protected them from a Candida fungal infection, showing it’s about 30 times more potent than the older thymus extract and about as strong as thymosin alpha‑1. The work is still early and only in animals, so it isn’t a ready‑to‑use protocol for humans yet.
In mice with an autoimmune thyroid disease, the peptide thymosin‑alpha‑1 changed immune cell balances in a dose‑ and timing‑dependent way, sometimes worsening the disease in resistant strains and sometimes reducing it in sensitive strains.
Ershler. W B WB; Hebert. J C JC; Blow. A J AJ; Granter. S R SR; Lynch. J J
In mice, older animals make fewer antibodies to the tetanus vaccine, but giving them thymosin‑alpha‑1 boosts those antibodies, while it doesn’t help against a pneumonia vaccine and older mice still die from infection. The peptide shows some age‑related immune‑boosting potential, but the evidence is limited to animal studies and doesn’t translate directly into a clear human protocol.
Ershler. W B WB; Moore. A L AL; Roessner. K K; Ranges. G E GE
In healthy older adults, immune cells make less interleukin‑2, but this isn’t tied to fewer helper T cells or weaker flu‑vaccine antibody responses, and adding thymosin‑α1 in the lab didn’t reliably raise IL‑2 levels.
The paper talks about how current hepatitis C treatments work well for some virus types but cause many side effects, so researchers are looking for new ways to fight the virus. One idea is to use immune‑boosting peptides like thymosin‑alpha‑1 together with existing drugs, but this is still in early clinical testing and not ready for everyday use.